Pfizer - 52 Year Stock Price History | PFE

Historical daily share price chart and data for Pfizer since 1972 adjusted for splits and dividends. The latest closing stock price for Pfizer as of December 09, 2024 is 26.10.
  • The all-time high Pfizer stock closing price was 53.46 on December 16, 2021.
  • The Pfizer 52-week high stock price is 31.54, which is 20.8% above the current share price.
  • The Pfizer 52-week low stock price is 24.48, which is 6.2% below the current share price.
  • The average Pfizer stock price for the last 52 weeks is 28.00.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Pfizer Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 27.2191 28.0233 30.9042 24.1739 26.1000 -3.82%
2023 33.9414 46.1886 46.1886 24.6299 27.1372 -41.22%
2022 44.2200 49.4486 49.4835 37.2991 46.1706 -10.42%
2021 36.2406 30.9126 53.4638 28.4304 51.5435 66.74%
2020 28.7975 29.9288 35.7414 22.0085 30.9126 3.18%
2019 30.0049 31.8914 33.3095 25.9291 29.9594 -6.92%
2018 28.4431 25.9429 34.0887 24.1634 32.1863 24.82%
2017 23.8447 22.6084 26.4840 21.3409 25.7863 15.88%
2016 22.1066 21.0837 25.0947 19.0372 22.2521 4.46%
2015 21.9087 20.0039 23.4777 19.8953 21.3015 7.10%
2014 19.0393 18.7826 20.4891 17.5344 19.8889 5.30%
2013 17.6135 15.4598 19.8556 15.4240 18.8874 26.22%
2012 13.6123 12.6172 15.3943 12.1556 14.9642 20.41%
2011 11.0010 9.7447 12.5368 9.4734 12.4277 28.77%
2010 9.0615 10.0122 10.5781 7.6301 9.6510 0.31%
2009 8.1654 9.1680 9.9699 5.9795 9.6208 8.26%
2008 9.3651 10.7730 11.3232 7.2511 8.8870 -16.85%
2007 11.6084 11.8117 12.7064 10.4862 10.6883 -8.15%
2006 11.3424 10.2989 12.6768 9.8877 11.6364 15.22%
2005 10.8959 11.1143 12.3200 8.9216 10.0996 -10.62%
2004 13.6965 14.6337 15.9921 10.2067 11.2992 -22.31%
2003 13.0176 12.7374 14.7543 11.5945 14.5431 17.76%
2002 13.9665 15.8849 16.7807 10.3887 12.3496 -22.16%
2001 16.5117 18.1797 18.1797 14.0916 15.8650 -12.49%
2000 16.3042 12.4534 19.2308 11.7503 18.1284 43.06%
1999 14.9888 15.9486 19.4173 12.3291 12.6722 -21.50%
1998 13.1414 9.6999 16.2843 9.4756 16.1423 68.94%
1997 7.1751 5.1813 9.9716 5.1813 9.5551 81.93%
1996 4.5986 3.8740 5.7267 3.7807 5.2521 33.96%
1995 2.9788 2.3139 4.1230 2.2719 3.9207 66.70%
1994 1.9599 2.0102 2.3937 1.5972 2.3520 15.31%
1993 1.8737 2.0838 2.1799 1.5651 2.0397 -2.28%
1992 2.1376 2.3711 2.4205 1.8867 2.0872 -11.97%
1991 1.6593 1.1059 2.4205 1.0301 2.3711 112.73%
1990 0.9296 0.9450 1.1249 0.7528 1.1146 20.50%
1989 0.8236 0.7418 0.9949 0.7022 0.9250 24.16%
1988 0.6785 0.6012 0.7562 0.6012 0.7450 29.21%
1987 0.8054 0.7601 0.9379 0.5148 0.5766 -22.90%
1986 0.7388 0.6130 0.8919 0.5762 0.7479 20.49%
1985 0.5668 0.4949 0.6835 0.4674 0.6207 19.83%
1984 0.4375 0.4430 0.5180 0.3678 0.5180 18.18%
1983 0.4725 0.4153 0.5486 0.4153 0.4383 3.81%
1982 0.3704 0.3218 0.4889 0.3080 0.4222 29.35%
1981 0.3016 0.3264 0.3356 0.2498 0.3264 0.00%
1980 0.2546 0.2299 0.3264 0.2000 0.3264 35.27%
1979 0.2044 0.2030 0.2498 0.1793 0.2413 18.87%
1978 0.1947 0.1678 0.2353 0.1563 0.2030 20.98%
1977 0.1638 0.1762 0.1762 0.1441 0.1678 -6.41%
1976 0.1731 0.1740 0.1916 0.1563 0.1793 4.92%
1975 0.1832 0.1969 0.2237 0.1471 0.1709 -14.55%
1974 0.2033 0.2651 0.2705 0.1325 0.2000 -24.56%
1973 0.2690 0.2674 0.3211 0.2383 0.2651 0.84%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $147.908B $58.496B
Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.?The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $762.851B 79.01
Novo Nordisk (NVO) Denmark $498.475B 35.95
Johnson & Johnson (JNJ) United States $360.180B 14.61
AbbVie (ABBV) United States $312.024B 16.42
Merck (MRK) United States $262.551B 17.44
AstraZeneca (AZN) United Kingdom $212.640B 18.09
Novartis AG (NVS) Switzerland $207.834B 13.81
Sanofi (SNY) $122.907B 11.13
Innoviva (INVA) United States $1.200B 9.98